Mogamulizumab

2012/06/01 by Joshuan M. Subramaniam, Joshuan Subramaniam, Glenn Whiteside +2 · 25 citations
Immunology and Microbiology · Medicine · #Antibody #Antibody-dependent cell-mediated cytotoxicity #CCR4 #Chemokine #Chemokine receptor #Cutaneous lymphoproliferative disorders research #Galectins and Cancer Biology #Immune system #Immunology #Lymphoma #Medicine #Monoclonal antibody #T-cell and Retrovirus Studies

paper · doi:10.2165/11631090-000000000-00000

openalex publication_date 2012/06/01 · openalex created_date 2016/06/24 · openalex updated_date 2026/07/25

Cited by

• Therapeutic efficacy of an Fc-enhanced TCR-like antibody to the intracellular WT1 oncoprotein. [europepmc]
• Fully human antagonistic antibodies against CCR4 potently inhibit cell signaling and chemotaxis. [europepmc]
• Tailored therapy for severe asthma. [europepmc]
• Antibodies targeting G protein-coupled receptors: Recent advances and therapeutic challenges. [europepmc]
• Chimeric antigen receptor modified T cells that target chemokine receptor CCR4 as a therapeutic modality for T-cell malignancies. [europepmc]
• A Review of New Findings in Adult T-cell Leukemia-Lymphoma: A Focus on Current and Emerging Treatment Strategies. [europepmc]
• Assessing the Heterogeneity of the Fc-Glycan of a Therapeutic Antibody Using an engineered FcγReceptor IIIa-Immobilized Column. [europepmc]
• The use of chimeric antigen receptor T cells in patients with non-Hodgkin lymphoma. [europepmc]
• CAR T-cells for T-cell malignancies: challenges in distinguishing between therapeutic, normal, and neoplastic T-cells. [europepmc]
• Pharmacokinetic and Pharmacodynamic Considerations in the Design of Therapeutic Antibodies. [europepmc]
• Chimeric Antigen Receptors for T-Cell Malignancies. [europepmc]
• In vitro affinity maturation of antibody against membrane-bound GPCR molecules. [europepmc]
• HTLV-1 Extracellular Vesicles Promote Cell-to-Cell Contact. [europepmc]
• Cutaneous barrier leakage and gut inflammation drive skin disease in Omenn syndrome. [europepmc]
• Novel Treatments of Adult T Cell Leukemia Lymphoma. [europepmc]
• Antigen Design for Successful Isolation of Highly Challenging Therapeutic Anti-GPCR Antibodies. [europepmc]
• Rhinovirus-induced CCL17 and CCL22 in Asthma Exacerbations and Differential Regulation by STAT6. [europepmc]
• Therapeutic Perspectives on the Modulation of G-Protein Coupled Estrogen Receptor, GPER, Function. [europepmc]
• Biology and Clinical Applicability of Plasma Thymus and Activation-Regulated Chemokine (TARC) in Classical Hodgkin Lymphoma. [europepmc]
• Functional Contribution and Targeted Migration of Group-2 Innate Lymphoid Cells in Inflammatory Lung Diseases: Being at the Right Place at the Right Time. [europepmc]
• Dermatologic Events Associated with the Anti-CCR4 Antibody Mogamulizumab: Characterization and Management. [europepmc]
• Trends and Perspectives of Biological Drug Approvals by the FDA: A Review from 2015 to 2021. [europepmc]
• Glycoconjugates: Synthesis, Functional Studies, and Therapeutic Developments. [europepmc]
• Therapeutic Targets of Monoclonal Antibodies Used in the Treatment of Cancer: Current and Emerging. [europepmc]
• Current State of Therapeutics for HTLV-1. [europepmc]